My Cart

MMP-9

MMP-9 Overview

English NameMatrix metalloproteinase 9Approved Drugs0
Drugs in Clinical Trials3Target SynonymType V Collagenase,Gelatinase B,EC 3.4.24.35,MANDP2,Matrix Metalloproteinase 9,CLG4B,MMP9,Matrix Metallopeptidase 9,Matrix Metalloproteinase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),GELB,Matrix Metalloproteinase-9,92 KDa Type IV Collagenase,Macrophage Gelatinase,92 kDa gelatinase,MMP-9,Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),EC:3.4.24.35,EC 3.4.24
Highest Development StagePhase 3 Clinical
English NameMatrix metalloproteinase 9
Target SynonymType V Collagenase,Gelatinase B,EC 3.4.24.35,MANDP2,Matrix Metalloproteinase 9,CLG4B,MMP9,Matrix Metallopeptidase 9,Matrix Metalloproteinase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),GELB,Matrix Metalloproteinase-9,92 KDa Type IV Collagenase,Macrophage Gelatinase,92 kDa gelatinase,MMP-9,Matrix Metallopeptidase 9 (Gelatinase B, 92kDa Gelatinase, 92kDa Type IV Collagenase),EC:3.4.24.35,EC 3.4.24
Approved Drugs0
Drugs in Clinical Trials3
Highest Development StagePhase 3 Clinical

MMP-9 Background

Matrix metallopeptidase 9 (MMP-9) is also known as 92 kDa type IV collagenase, 92 kDa gelatinase or gelatinase B (GELB), CLG4B, is secreted from neutrophils, macrophages, and a number of transformed cells, and is the most complex family member in terms of domain structure and regulation of its activity. . Structurally, MMP9 maybe be divided into five distinct domains: a prodomain which is cleaved upon activation, a gelatinbinding domain consisting of three contiguous fibronectin type II units, a catalytic domain containing the zinc binding site, a prolinerich linker region, and a carboxyl terminal hemopexinlike domain. This enzyme degrades various substrates including gelatin, collagen types IV and V, and elastin. MMP9 is involved in a variety of autoimmune diseases such as systemic lupus erythematosus, rheumatoid arthritis, and multiple sclerosis, and be regarded as a potential therapeutic target.

MMP-9 Synonyms

MMP9,CLG4B,GELB,MANDP2,Gelatinase B

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
AndecaliximabGS-5745Phase 3 ClinicalGilead IncCystic Fibrosis; Esophageal Neoplasms; Stomach Neoplasms; Arthritis, Rheumatoid; Pancreatic Neoplasms; Breast Neoplasms; Colitis, Ulcerative; Myositis Ossificans; Colorectal Neoplasms; Pulmonary Disease, Chronic Obstructive; Crohn Disease; Carcinoma, Non-Small-Cell Lung
Details
AQU-005AQU-005; NMAQU-005; NM-AQU-005Phase 1 ClinicalAquilus PharmaceuticalsNeuralgia
Details
CALY-001CALY-001ClinicalCalypso Biotech BvInflammatory Bowel Diseases; Crohn Disease
Details
  • Overview
  • Product List
  • Clinical Drug Information
Contact Us

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521

[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland